TD ASSET MANAGEMENT INC - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 146 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2015$505,000
-19.1%
293,400
-0.7%
0.00%0.0%
Q3 2015$624,000
-56.7%
295,600
+1.5%
0.00%
-66.7%
Q2 2015$1,442,000
-39.8%
291,300
-4.8%
0.00%
-25.0%
Q1 2015$2,397,000
+44.3%
306,100
+11.7%
0.00%
+33.3%
Q4 2014$1,661,000
+31.7%
274,100
-7.4%
0.00%
+50.0%
Q3 2014$1,261,000
+7.8%
295,900
+56.2%
0.00%0.0%
Q2 2014$1,170,000
+92.4%
189,400
+102.4%
0.00%
+100.0%
Q1 2014$608,000
+247.4%
93,600
+213.0%
0.00%
Q2 2013$175,00029,9000.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,250,000$7,725,0006.48%
Ghost Tree Capital, LLC 250,000$1,545,0001.09%
Rock Springs Capital Management LP 905,000$5,593,0001.00%
Palo Alto Investors LP 1,931,324$11,936,0000.89%
PFM Health Sciences, LP 4,604,958$28,459,0000.57%
NEA Management Company, LLC 1,935,300$11,960,0000.56%
Rhenman & Partners Asset Management AB 300,199$1,855,0000.55%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 1,752,792$10,832,0000.50%
CQS Cayman LP 660,040$4,079,0000.25%
FARALLON CAPITAL MANAGEMENT LLC 2,684,300$16,589,0000.24%
View complete list of OREXIGEN THERAPEUTICS INC shareholders